A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)
Incyte Corporation
Incyte Corporation
City of Hope Medical Center
Columbia University
City of Hope Medical Center
Pfizer
Eisai Inc.
Rutgers, The State University of New Jersey
University of Nebraska
University of Nebraska
Columbia University
Bristol-Myers Squibb
Memorial Sloan Kettering Cancer Center
miRagen Therapeutics, Inc.
Incyte Corporation
National Institutes of Health Clinical Center (CC)
Roswell Park Cancer Institute
Galderma R&D
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Northwestern University
Mayo Clinic
Mayo Clinic
Northwestern University
Barbara Ann Karmanos Cancer Institute
University of Texas Southwestern Medical Center
Northwestern University
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Massachusetts General Hospital
Fred Hutchinson Cancer Center
Alliance for Clinical Trials in Oncology
Mayo Clinic
Alliance for Clinical Trials in Oncology
University of Rochester
Barbara Ann Karmanos Cancer Institute
Valerio Therapeutics
City of Hope Medical Center
M.D. Anderson Cancer Center
Vanderbilt-Ingram Cancer Center
Pharmacyclics LLC.
Altor BioScience
Vanderbilt-Ingram Cancer Center
M.D. Anderson Cancer Center